Director/PDMR Shareholding – acquisition of shares

Transense Technologies PLC
18 June 2024

18 June 2024


Transense Technologies plc

("Transense" or the "Company")


Director/PDMR shareholding - acquisition of shares


Transense Technologies plc, the provider of specialist sensor technology and measurement systems, has been notified that on 17 June 2024, Ryan Maughan, Managing Director, purchased 3,946 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 126.5 pence per share. Accordingly, Ryan Maughan's total beneficial shareholding in the Company has increased to 59,300 Ordinary Shares, which represents approximately 0.39% of the Company's current voting rights.


Further details are provided in the form below in accordance with the requirements of the UK Market Abuse Regulation.


For further information please visit or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (Chief Financial Officer)

Ryan Maughan (Managing Director)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/George Payne (Corporate Finance)

Stefano Aquilino/Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joesph Walker

Tel: +44 (0)20 7933 8780


Notes to Editors:

Transense is a developer of specialist sensor technology and measurement systems.  The Company has two active business divisions:


·     Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and


·     SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.


In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.


The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.


Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.


For further information please contact



Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them




Details of the person discharging managerial responsibilities / person closely associated






Ryan Maughan



Reason for the notification






Managing Director



Initial notification /Amendment





Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor






Transense Technologies plc








Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 




Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence each

Identification code




Nature of the transaction 


Purchase of Ordinary Shares


Price and volume

Price: 126.5 pence per share


Volume: 3,946



Aggregated information

- Aggregated volume

As above

- Price



Date of the transaction


17 June 2024



Place of the transaction


London Stock Exchange, AIM


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings